Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Pathways (CLPA) -- Ignore unavailable to you. Want to Upgrade?

To: bob who wrote (41)	11/16/1998 9:26:00 AM
From: Mike J	Read Replies (1) \| Respond to of 566

Did all of you CLPA fans know of Bayer's new prospective drug in Phase III clinical trials? Their drug supposedly uses the same basic technique as CLPA to fight cancerous cells, but Bayer's drug is intended to treat both lung cancer and pancreatic cancer (how it can treat both I do not understand). Join the club, bob - I don't have level II, either. No time to look in that kind of detail. Also, not a trader. More of a momentum kinda guy with smaller co's (except for ones with actual promise).